Skip to content

Enovis ENOV Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
Stryker logo
StrykerSYK
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
ESAB logo
ESABESAB
Vericel logo
VericelVCEL
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-40.2%
Enterprise value$2.55B-25.8%
P/S0.5×-0.4×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's software and technology licenses, net?
Enovis (ENOV) reported software and technology licenses, net of $93.96M in Q1 2026.
How has Enovis's software and technology licenses, net changed year-over-year?
Enovis's software and technology licenses, net increased by 8.3% year-over-year, from $86.74M to $93.96M.
What is the long-term trend for Enovis's software and technology licenses, net?
Over 5 years (2020 to 2025), Enovis's software and technology licenses, net has grown at a -23.3% compound annual growth rate (CAGR), from $350.83M to $93.35M.